Agilent Technologies (NYSE:A) has been given a consensus recommendation of “Buy” by the sixteen brokerages that are covering the company, Marketbeat reports. Three equities research analysts have rated the stock with a hold recommendation and thirteen have assigned a buy recommendation to the company. The average twelve-month target price among analysts that have covered the stock in the last year is $72.79.
Several analysts have commented on the stock. JPMorgan Chase lifted their price objective on shares of Agilent Technologies from $75.00 to $80.00 and gave the company an “overweight” rating in a research note on Thursday, February 15th. Zacks Investment Research upgraded shares of Agilent Technologies from a “hold” rating to a “buy” rating and set a $80.00 price objective for the company in a research note on Tuesday, March 13th. ValuEngine cut shares of Agilent Technologies from a “buy” rating to a “hold” rating in a research note on Wednesday, March 7th. Morgan Stanley lifted their price objective on shares of Agilent Technologies from $90.00 to $95.00 and gave the company an “overweight” rating in a research note on Monday, April 2nd. Finally, Goldman Sachs upgraded shares of Agilent Technologies from a “neutral” rating to a “buy” rating in a research note on Monday, April 9th.
In other news, VP Rodney Gonsalves sold 6,825 shares of the company’s stock in a transaction on Tuesday, March 13th. The shares were sold at an average price of $71.23, for a total transaction of $486,144.75. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Patrick Kaltenbach sold 4,000 shares of the company’s stock in a transaction on Thursday, March 29th. The stock was sold at an average price of $67.28, for a total transaction of $269,120.00. Following the sale, the insider now directly owns 72,547 shares of the company’s stock, valued at approximately $4,880,962.16. The disclosure for this sale can be found here. Insiders have sold 22,700 shares of company stock valued at $1,586,452 in the last ninety days.
Hedge funds have recently made changes to their positions in the company. Leucadia National Corp acquired a new position in shares of Agilent Technologies during the 4th quarter valued at about $1,647,000. State of Alaska Department of Revenue boosted its position in shares of Agilent Technologies by 190.2% during the 4th quarter. State of Alaska Department of Revenue now owns 57,154 shares of the medical research company’s stock valued at $3,826,000 after acquiring an additional 37,460 shares during the last quarter. BlackRock Inc. boosted its position in shares of Agilent Technologies by 8.1% during the 4th quarter. BlackRock Inc. now owns 25,665,358 shares of the medical research company’s stock valued at $1,718,808,000 after acquiring an additional 1,912,186 shares during the last quarter. Rhumbline Advisers boosted its position in shares of Agilent Technologies by 1.7% during the 4th quarter. Rhumbline Advisers now owns 558,724 shares of the medical research company’s stock valued at $37,418,000 after acquiring an additional 9,438 shares during the last quarter. Finally, Sciencast Management LP lifted its position in Agilent Technologies by 30.9% in the fourth quarter. Sciencast Management LP now owns 18,148 shares of the medical research company’s stock valued at $1,326,000 after buying an additional 4,279 shares during the last quarter.
A stock traded up $0.73 during trading on Monday, reaching $64.32. The company had a trading volume of 4,163,534 shares, compared to its average volume of 3,228,449. The company has a quick ratio of 2.78, a current ratio of 3.32 and a debt-to-equity ratio of 0.39. Agilent Technologies has a twelve month low of $55.85 and a twelve month high of $75.00. The stock has a market capitalization of $20.51 billion, a PE ratio of 27.25, a price-to-earnings-growth ratio of 2.22 and a beta of 1.32.
Agilent Technologies (NYSE:A) last announced its quarterly earnings data on Monday, May 14th. The medical research company reported $0.65 EPS for the quarter, beating the consensus estimate of $0.64 by $0.01. Agilent Technologies had a net margin of 5.02% and a return on equity of 18.01%. The business had revenue of $1.21 billion during the quarter, compared to analysts’ expectations of $1.21 billion. During the same period in the previous year, the business posted $0.58 EPS. The business’s quarterly revenue was up 9.4% compared to the same quarter last year. equities research analysts expect that Agilent Technologies will post 2.67 earnings per share for the current year.
The business also recently declared a quarterly dividend, which will be paid on Wednesday, July 25th. Investors of record on Tuesday, July 3rd will be issued a $0.149 dividend. This represents a $0.60 annualized dividend and a yield of 0.93%. The ex-dividend date of this dividend is Monday, July 2nd. Agilent Technologies’s payout ratio is presently 25.42%.
Agilent Technologies Company Profile
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; microfluidics based automated electrophoresis products; cell analysis plate based assays; laboratory software and informatics systems; laboratory automation; dissolution testing; vacuum pumps; and measurement technologies.
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.